Detalhe da pesquisa
1.
Multi-omic machine learning predictor of breast cancer therapy response.
Nature
; 601(7894): 623-629, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34875674
2.
Non-genetic determinants of malignant clonal fitness at single-cell resolution.
Nature
; 601(7891): 125-131, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34880496
3.
Seven-year outcomes of venetoclax-ibrutinib therapy in mantle cell lymphoma: durable responses and treatment-free remissions.
Blood
; 2024 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38662991
4.
HBO1 is required for the maintenance of leukaemia stem cells.
Nature
; 577(7789): 266-270, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31827282
5.
CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity.
Nature
; 549(7670): 101-105, 2017 09 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28813417
6.
Potential Clinical Utility of a Targeted Circulating Tumor DNA Assay in Esophageal Adenocarcinoma.
Ann Surg
; 276(2): e120-e126, 2022 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35737908
7.
Modeling the Prognostic Impact of Circulating Tumor Cells Enumeration in Metastatic Breast Cancer for Clinical Trial Design Simulation.
Oncologist
; 27(7): e561-e570, 2022 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35278078
8.
Coding and noncoding drivers of mantle cell lymphoma identified through exome and genome sequencing.
Blood
; 136(5): 572-584, 2020 07 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-32160292
9.
Ibrutinib plus Venetoclax for the Treatment of Mantle-Cell Lymphoma.
N Engl J Med
; 378(13): 1211-1223, 2018 03 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-29590547
10.
BET inhibitor resistance emerges from leukaemia stem cells.
Nature
; 525(7570): 538-42, 2015 Sep 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-26367796
11.
Clinical implications of prospective genomic profiling of metastatic breast cancer patients.
Breast Cancer Res
; 22(1): 91, 2020 08 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-32811538
12.
Circulating tumour DNA in metastatic breast cancer to guide clinical trial enrolment and precision oncology: A cohort study.
PLoS Med
; 17(10): e1003363, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33001984
13.
Molecular disease monitoring using circulating tumor DNA in myelodysplastic syndromes.
Blood
; 129(12): 1685-1690, 2017 03 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-28126926
14.
The value of cell-free DNA for molecular pathology.
J Pathol
; 244(5): 616-627, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29380875
15.
Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA.
Nature
; 497(7447): 108-12, 2013 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-23563269
16.
Correction to: Clinical implications of prospective genomic profiling of metastatic breast cancer patients.
Breast Cancer Res
; 24(1): 50, 2022 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35841108
17.
Correction: The Subclonal Architecture of Metastatic Breast Cancer: Results from a Prospective Community-Based Rapid Autopsy Program "CASCADE".
PLoS Med
; 14(4): e1002302, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28430777
18.
A new genome-driven integrated classification of breast cancer and its implications.
EMBO J
; 32(5): 617-28, 2013 Mar 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-23395906
19.
The Subclonal Architecture of Metastatic Breast Cancer: Results from a Prospective Community-Based Rapid Autopsy Program "CASCADE".
PLoS Med
; 13(12): e1002204, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28027312
20.
Analysis of circulating tumor DNA to monitor metastatic breast cancer.
N Engl J Med
; 368(13): 1199-209, 2013 Mar 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-23484797